(Q39543905)

12 September 2017

1 reference

title

Estrogens in the prevention and treatment of postmenopausal osteoporosis: a review (English)

1 reference

postmenopausal osteoporosis

12 September 2017

0 references

1 reference

1 reference

U S Barzel

1

1 reference

PubMed ID

3057904

12 September 2017

language of work or name

English

0 references

publication date

1 December 1988

1 reference

American Journal of Medicine

12 September 2017

1 reference

12 September 2017

85

1 reference

12 September 2017

6

1 reference

12 September 2017

847-850

1 reference

POSTMENOPAUSAL OSTEOPOROSIS

12 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Oestrogen replacement therapy for prevention of osteoporosis after oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Bone response to termination of oestrogen treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Prevention of spinal osteoporosis in oophorectomised women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Quantitative Computed Tomography of Vertebral Spongiosa: A Sensitive Method for Detecting Early Bone Loss After Oophorectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Post-menopausal oestrogens protect against fractures of hip and distal radius. A case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Menopausal estrogen therapy and hip fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

An epidemiologic study of hip fracture in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Long-term estrogen replacement therapy prevents bone loss and fractures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Prospective trial of oestrogen and calcium in postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Factors in response to treatment of early postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

The effect of estrogen dose on postmenopausal bone loss

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Does calcium supplementation prevent postmenopausal bone loss? A double-blind, controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

A prospective study of postmenopausal estrogen therapy and coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Estrogen use and cardiovascular disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

EFFECTS OF ANDROGENS, ESTROGENS AND HIGH CALCIUM INTAKES ON BONE FORMATION AND RESORPTION IN OSTEOPOROSIS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

A review of the prolonged use of estrogens and androgens in postmenopausal and senile osteoporosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Three-year changes in bone mineral mass of postmenopausal osteoporotic patients based on neutron activation analysis of the central third of the skeleton

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Treatment of spinal osteoporosis in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2888%2980033-0

10.1016/S0002-9343(88)80033-0

7 January 2021

Identifiers

DOI

1 reference

12 September 2017

1 reference

PubMed ID

3057904